![](https://investorshub.advfn.com/uicon/220347.png?cb=1693474201)
Tuesday, January 17, 2017 4:28:08 PM
IMO instead I think what were seeing here is what can happen when the person running the show is a former top Wall Street biotechnology analyst and has the connections to go with it.
Now combine that with a fantastic looking company, with an extremely strong pipeline of drugs, a $100M nanotechnology/transdermal platform and currently conducting research and development into nano and transdermal cannabinoids(see Zynerba (NASDAQ: ZYNE currently sitting @ $19.50 pps) and I think you'll understand the interest.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM